
Living with Anemia, nonspherocytic hemolytic, due to G6PD deficiency
A genetic condition in which red blood cells break down early, often after infections, certain drugs, or fava beans.
Understanding Anemia, nonspherocytic hemolytic, due to G6PD deficiency
A defect in an enzyme called glucose-6-phosphate dehydrogenase causes red blood cells to break down early, which is called hemolysis. The most common problem is hemolytic anemia, when cells are destroyed faster than the body can replace them. It is most often triggered by infections or certain drugs, such as some antibiotics and malaria medicines. It can also follow eating fava beans or breathing in fava plant pollen (favism).
Signs & symptoms
Symptoms vary from person to person. GARD lists these among the most common:
- Pale skin
- Yellowing of the skin and eyes (jaundice)
- Dark urine
- Tiredness and shortness of breath
- Fast heart rate
- Belly pain and fever
Not everyone has every symptom. GARD's list comes from the Human Phenotype Ontology.
Diagnosis
- 1Talk with your doctor
Share the symptoms you've noticed, when they started and your family health history. Notes and photos can help.
- 2See a specialist
Specialists who may be involved include blood and bone marrow specialists and genetic specialists.
- 3Consider genetic testing
Changes in G6PD are linked to this condition. Genetic testing and counseling can help confirm a diagnosis and explain what it means for your family.
Care & treatment
- Care team
- Blood and bone marrow specialists (hematologists); Genetic specialists (geneticists)
- Expert care
- Ask about multidisciplinary care centers for rare conditions
- Treatment
- GARD doesn't list specific treatments for this condition. Your care team will tailor care to your symptoms.
- Research
- Clinical trials and observational studies may be options. See the research section below.
General information, not medical advice. Your care team makes the decisions.
Everyday life
Living with a rare condition is easier with support.
- Connect with g6pd Deficiency Foundation
- Keep notes on symptoms, changes and questions for appointments
- Ask about patient registries that help research
- Look into financial aid and travel resources for care visits
Quick facts
Changes in the G6PD gene cause this condition, and it is inherited in an X-linked way.
Also known as: anemia, congenital, nonspherocytic hemolytic, 1; anemia, congenital, nonspherocytic hemolytic, 1, g6pd deficient; class i g6pd deficiency; class i glucose-6-phosphate dehydrogenase deficiency; cnsha1; favism, susceptibility to
Patient organizations
- g6pd Deficiency FoundationAnemia, nonspherocytic hemolytic, due to G6PD deficiency · United States
You are more than your diagnosis
Perspectives from people navigating life with Anemia, nonspherocytic hemolytic, due to G6PD deficiency.
Explore research for Anemia, nonspherocytic hemolytic, due to G6PD deficiency
Explore actively recruiting Anemia, nonspherocytic hemolytic, due to G6PD deficiency studies with HealthSpark.
Find actively recruiting studies for Anemia, nonspherocytic hemolytic, due to G6PD deficiency with HealthSpark. Share your city to explore research near you.
- Recruiting studies from ClinicalTrials.gov
- Share your city to look for research near you
- Eligibility is confirmed by the study team
Powered by HealthSpark, our AI chat helper
I can help you find recruiting Anemia, nonspherocytic hemolytic, due to G6PD deficiency studies. Enter a ZIP code, address or city below and I'll look within 50 miles.
Powered by HealthSpark, our AI chat helper · Study information from ClinicalTrials.gov · Eligibility is confirmed by the study team.
Get Signals for Anemia, nonspherocytic hemolytic, due to G6PD deficiency
Stay in the loop with community stories and updates from medical researchers.
Create a living journal that talks back
HealthStory evolves private journaling with a living AI journal that talks back and asks thoughtful questions, helping you capture your Anemia, nonspherocytic hemolytic, due to G6PD deficiency experiences more deeply and prepare for better conversations with your doctors and care team.
Your journal is private. Sharing your story publicly is a separate choice, made with Share your story above.



